FMR LLC 13D and 13G filings for Viking Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 5,772,051 5.100% | -3,995,847 (-40.91%) | Filing |
| 2025-08-06 12:19 pm Sale | 2025-06-30 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 9,767,898 8.700% | -1,481,440 (-13.17%) | Filing |
| 2025-05-12 10:43 am Sale | 2025-03-31 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 11,249,337 10.000% | -3,755,003 (-25.03%) | Filing |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 15,004,340 14.999% | 4,081,593 (+37.37%) | Filing |
| 2023-04-10 09:37 am Purchase | 2023-04-06 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 10,922,747 11.418% | 8,736,380 (+399.58%) | Filing |